323 related articles for article (PubMed ID: 15916037)
1. Factors associated with treatment outcomes in pulmonary tuberculosis in northeastern Thailand.
Anunnatsiri S; Chetchotisakd P; Wanke C
Southeast Asian J Trop Med Public Health; 2005 Mar; 36(2):324-30. PubMed ID: 15916037
[TBL] [Abstract][Full Text] [Related]
2. Treatment outcomes by drug resistance and HIV status among tuberculosis patients in Ho Chi Minh City, Vietnam.
Quy HT; Cobelens FG; Lan NT; Buu TN; Lambregts CS; Borgdorff MW
Int J Tuberc Lung Dis; 2006 Jan; 10(1):45-51. PubMed ID: 16466036
[TBL] [Abstract][Full Text] [Related]
3. Anti-tuberculosis drug resistance and HIV co-infection in Phnom Penh, Cambodia.
Sar B; Keo C; Leng C; Saman M; Min DC; Chan S; Monchy D; Sarthou JL
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):104-7. PubMed ID: 19323041
[TBL] [Abstract][Full Text] [Related]
4. [Mycobacterium tuberculosis drug resistance in patients with HIV and pulmonary tuberculosis infections in Rome: 1987-1996].
Palmieri F; Pellicelli AM; Girardi E; Rianda A; Bordi E; Festa A; Catania S; D'Amato C
Ann Ital Med Int; 1998; 13(3):139-45. PubMed ID: 9859569
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of drug-resistant tuberculosis in an HIV endemic area in northern Thailand.
Yoshiyama T; Supawitkul S; Kunyanone N; Riengthong D; Yanai H; Abe C; Ishikawa N; Akarasewi P; Payanandana V; Mori T
Int J Tuberc Lung Dis; 2001 Jan; 5(1):32-9. PubMed ID: 11263513
[TBL] [Abstract][Full Text] [Related]
6. [Epidemiology of the resistance of Mycobacterium tuberculosis to antituberculosis drugs at the main hospital in Dakar, Senegal. A 4-year retrospective study (2000-2003)].
Chevalier B; Margery J; Sane M; Camara P; Lefebvre N; Gueye M; Thiam M; Perrier-Gros-Claude JD; Simon F; Fabre M; Soler C; Herve V; Mbaye PS; Debonne JM
Rev Pneumol Clin; 2010 Sep; 66(4):266-71. PubMed ID: 20933169
[TBL] [Abstract][Full Text] [Related]
7. [Drug resistance of Mycobacterium tuberculosis in Orizaba, Veracruz. Implications for the tuberculosis prevention and control program].
García-García ML; Sifuentes-Osornio J; Jiménez-Corona ME; Ponce-de-León A; Jiménez-Corona A; Bobadilla-del Valle M; Palacios-Martínez M; Canales G; Sanginés A; Jaramillo Y; Martínez-Gamboa A; Balandrano S; Valdespino-Gómez JL; Small P
Rev Invest Clin; 2001; 53(4):315-23. PubMed ID: 11599478
[TBL] [Abstract][Full Text] [Related]
8. Drug resistance pulmonary tuberculosis in the Eastern Province of Saudi Arabia.
Al-Rubaish AM; Madania AA; Al-Muhanna FA
Saudi Med J; 2001 Sep; 22(9):776-9. PubMed ID: 11590451
[TBL] [Abstract][Full Text] [Related]
9. Treatment results of DOTS in 1797 Sudanese tuberculosis patients with or without HIV co-infection.
El-Sony AI; Khamis AH; Enarson DA; Baraka O; Mustafa SA; Bjune G
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1058-66. PubMed ID: 12546113
[TBL] [Abstract][Full Text] [Related]
10. Mortality and failure among tuberculosis patients who did not complete treatment in Vietnam: a cohort study.
Vree M; Huong NT; Duong BD; Sy DN; Van le N; Co NV; Cobelens FG; Borgdorff MW
BMC Public Health; 2007 Jul; 7():134. PubMed ID: 17605770
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with treatment success for tuberculosis patients: a single center's experience in Turkey.
Talay F; Kumbetli S; Altin S
Jpn J Infect Dis; 2008 Jan; 61(1):25-30. PubMed ID: 18219130
[TBL] [Abstract][Full Text] [Related]
12. Identification of drug susceptibility pattern and mycobacterial species in sputum smear positive pulmonary tuberculosis patients with and without HIV co-infection in north west Ethiopia.
Mekonen M; Abate E; Aseffa A; Anagaw B; Elias D; Hailu E; Idh J; Moges F; Wolde-Amanuel Y; Asrat D; Yamuah L; Britton S; Stendahl O; Schön T
Ethiop Med J; 2010 Jul; 48(3):203-10. PubMed ID: 21073081
[TBL] [Abstract][Full Text] [Related]
13. Treatment outcome of relapse and defaulter pulmonary tuberculosis patients.
Sevim T; Ataç G; Güngör G; Törün I; Aksoy E; Gemci ; Tahaoglu K
Int J Tuberc Lung Dis; 2002 Apr; 6(4):320-5. PubMed ID: 11936741
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis retreatment category predicts resistance in hospitalized retreatment patients in a high HIV prevalence area.
Schreiber YS; Herrera AF; Wilson D; Wallengren K; Draper R; Muller J; Dawood H; Doucette S; Cameron DW; Alvarez GG
Int J Tuberc Lung Dis; 2009 Oct; 13(10):1274-80. PubMed ID: 19793433
[TBL] [Abstract][Full Text] [Related]
15. 'Smear-negative' pulmonary tuberculosis in a DOTS programme: poor outcomes in an area of high HIV seroprevalence.
Hargreaves NJ; Kadzakumanja O; Whitty CJ; Salaniponi FM; Harries AD; Squire SB
Int J Tuberc Lung Dis; 2001 Sep; 5(9):847-54. PubMed ID: 11573897
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance.
Cox H; Kebede Y; Allamuratova S; Ismailov G; Davletmuratova Z; Byrnes G; Stone C; Niemann S; Rüsch-Gerdes S; Blok L; Doshetov D
PLoS Med; 2006 Oct; 3(10):e384. PubMed ID: 17020405
[TBL] [Abstract][Full Text] [Related]
17. Tuberculosis in Thai prisons: magnitude, transmission and drug susceptibility.
Sretrirutchai S; Silapapojakul K; Palittapongarnpim P; Phongdara A; Vuddhakul V
Int J Tuberc Lung Dis; 2002 Mar; 6(3):208-14. PubMed ID: 11934138
[TBL] [Abstract][Full Text] [Related]
18. Anti-tuberculosis drug resistance in new and previously treated pulmonary tuberculosis cases in Burkina Faso.
Sangaré L; Diandé S; Badoum G; Dingtoumda B; Traoré AS
Int J Tuberc Lung Dis; 2010 Nov; 14(11):1424-9. PubMed ID: 20937182
[TBL] [Abstract][Full Text] [Related]
19. Treatment monitoring and prevalence of drug resistance in tuberculosis patients in Tehran.
Bahrmand AR; Velayati AA; Bakayev VV
Int J Tuberc Lung Dis; 2000 Jun; 4(6):544-9. PubMed ID: 10864185
[TBL] [Abstract][Full Text] [Related]
20. Five year review of treatment outcome of directly observed therapy (DOT) for re-treatment pulmonary tuberculosis patients in UCH, Ibadan, Nigeria.
Ige OM; Akindele MO
Afr J Med Med Sci; 2011 Mar; 40(1):15-21. PubMed ID: 21834257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
